2002

Weber J., Mesters J.R., Lepšík M., Prejdová J., Švec M., Šponarová J., Mlčochová P., Skalická K., Stříšovský K., Uhlíková T., Souček M., Machala L., Staňková M., Vondrášek J., Klimkait T., Kraeusslich H.-G., Hilgenfeld R., Konvalinka J.:
Unusual binding mode of an HIV-1 protease inhibitor explains its potency against multi-drug-resistant virus strains.
Journal of Molecular Biology 4 (324): 739-754, 2002.

Dohnálek J., Hašek J., Dušková J., Petroková H., Hradílek M., Souček M., Konvalinka J., Brynda J., Sedláček J., Fábry M.:
Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor.
Journal of Medicinal Chemistry 7 (45): 1432-1438, 2002.

Stříšovský K., Smrž D., Fehrmann F., Krausslich H.-G., Konvalinka J.:
The murine endogenous retrovirus MIA14 encodes an active aspartic proteinase that is functionally similar to proteinases from D-type retroviruses.
Archives of Biochemistry and Biophysics 2 (398): 261-268, 2002.

Bařinka C., Rinnová M., Šácha P., Rojas C., Majer P., Slusher B.S., Konvalinka J.:
Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.
Journal of Neurochemistry 3 (80): 477-487, 2002.